In both humans and non-human animal model systems, pathological findings show that cognitive impairment in Alzheimer’s disease and its neural degeneration are specifically associated with amyloid and tau depositions in myriad brain regions, including the medial and lateral temporal lobes and several parietal regions.1-7. Here, MAPT is linked to amyloidosis.